Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 868 results for "ranbaxy industries"

India's Sun Pharma sees multiyear earnings hit as it fixes pla...

Sun Pharma Managing Director Dilip Shanghvi Sun Pharmaceutical Industries founder and managing director Dilip Shanghvi said earlier this year his first priority after the purchase of Ranbaxy Laboratories was to solve regulatory and integration ... Fierce Biotech IT, 4 days ago
Sun Pharma MD Dilip Shanghvi expects own products in 2-3 yrs Business Standard India, 21 hours ago
India Infoline

Top Pharma news of the day

Sun Pharmaceutical Industries is cutting staff again as it digests the $3.2-billion acquisition of Ranbaxy Laboratories. Facing the axe this time are research and development staff, a move that comes a month after about 150 senior executives were asked to ...
 India Infoline1 day ago After Cutting 150 Ranbaxy Laboratories (RANBAXY.BO) Execs, Sun Pharma (SUNPHARMA.NS) Takes the Ax to Some R&D Workers 7/30/2015  ClinicSpace20 hours ago After acquiring Ranbaxy for $3.2 bn, Sun Pharma cuts staff in R&D division  Economic Times1 day ago Sun Pharma cuts staff in R&D division  Economic Times1 day ago
International Business Times India

Sun Pharma warns on revenue, profit due to Ranbaxy takeover [Mint, New Delhi]

July 21--MUMBAI -- Sun Pharmaceutical Industries Ltd India's largest drugmaker by sales said it expects consolidated revenue to either remain flat or show a decline from a year earlier. "As a part of the integration process, the company expects to ...
 Bloomberg1 week ago India's Sun Pharma expects Ranbaxy costs to hit 2016 revenue  Reuters India1 week ago Sun Pharma Shares Plunge over 15% on Profit Warning  International Business Times India1 week ago Sun Pharma profit alert  The Telegraph1 week ago
[x]  

Sun Pharma cuts projections on integration of Ranbaxy

Sun Pharmaceutical Industries, a Rs. 27,000 crore Indian pharma giant after merging Ranabxy Laboratories, has cut down its sales and profit projections for the year ended March 2015 on account of amalgamation of Ranbaxy Laboratories. The sales are ...
 PharmaBiz1 week ago
DNA

Post merger: Sun Pharma asks some Ranbaxy workmen to leave

Friday, 19 June 2015 | PTI | New Delhi Sun Pharmaceutical Industries has started easing out excess employees from Ranbaxy, including senior executives, following completion of its $4 billion acquisition of the Gurgaon-based firm.When asked to ...
 New Delhi Pioneer1 month ago Ranbaxy exec shown the door  News Today1 month ago Sun Pharma asks some Ranbaxy employees to leave, post merger  Business Standard1 month ago Top executives in Ranbaxy shown the door as Sun Pharma takes charge  DNA1 month ago
[x]  

Sun Pharma shares rise; HSBC says buy, Ranbaxy Halol key

Shares of Sun Pharmaceutical Industries advanced more than 1 percent intraday Thursday. Brokerage HSBC advises buying the stock with a target price of Rs 1,043. The brokerage says US sales contribution increased marginally to 90 percent, driven ...
 Moneycontrol.com4 weeks ago Sun Pharma up 3%, raises Ranbaxy's products prices in US  Moneycontrol.com1 month ago BUZZ-India's Sun Pharma rises; Credit Suisse says Ranbaxy drug prices hiked  Reuters India1 month ago
DNA

Sun Pharma Q4 profit at Rs 888 cr; Ranbaxy merger hurts

Sun Pharmaceutical Industries today posted a consolidated net profit of Rs 888.05 crore for the fourth quarter ended March 31, mainly due to Ranbaxy merger impact and price erosion in some products in the US. The company had posted a net profit of ...
 Business Standard2 months ago Sun Pharma shares tank 11%; weak earnings seen culprit  DNA1 month ago Sun Pharma aims USD 250 mn synergy in 3 years post Ranbaxy integration: Uday Baldota  India Infoline1 month ago Merger hurts Sun  The Telegraph2 months ago

Ex-Ranbaxy top executive rolls out drug delivery startup [India Business] [Times of India]

MUMBAI: Pharma industry veteran Rajiv Gulati, who quit last year as president Ranbaxy, is floating a start-up which offers a 'mail order service' for chronic medicines, particularly for patients suffering from hypertension and diabetes. mChemist ...
 Pharmacy Choice3 weeks ago Ex-Ranbaxy top executive Rajiv Gulati rolls out drug delivery startup  Economic Times4 weeks ago
Business Standard

No decision on plant closures but will optimise network: Sun Pharma

Sun Pharmaceutical Industries, which recently completed a $3.2-billion acquisition of Ranbaxy Laboratories, is considering rationalising its manufacturing network. Of the combined entity's 45 manufacturing plants, 21 are Ranbaxy's. Chief Financial ...
 Smart Investor4 weeks ago
Livemint.com

Sun Pharma-Ranbaxy: honeymoon over, now to make it work

New Delhi, June 1 -- The first financial results of Sun Pharmaceutical Industries Ltd and Ranbaxy Laboratories Ltd after they became one is likely to leave the market puzzled. The Street may even push down its share a notch or two after seeing the ...
 HT Syndication1 month ago Sun Pharma-Ranbaxy merger: honeymoon over, now to make it work  Livemint.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less